Instead of manually rebuilding certificate attachments for every review, use an IRB peptide documentation workflow that connects each uploaded COA to its lot, analytical evidence, and institutional review record. This 2026 guide builds a traceable laboratory documentation packet—not permission to administer research peptides to people or animals.
- An IRB peptide documentation workflow connects lot records, COA evidence, and institutional review decisions—not authorization for administration.
- Strandaminos research peptides are for laboratory researchers; supplier certificates do not establish suitability for human research.
- HPLC and mass-spec evidence answer different analytical questions; retain their methods, identifiers, and limitations.
- Research use only. Not for human or veterinary use.
Why this matters
A Certificate of Analysis, or COA, documents reported analytical results for an identified sample. An institutional review board, or IRB, reviews human-subjects research within its authority. A COA is not an IRB approval, and an IRB decision does not expand a supplier's research-use restrictions.
Strandaminos sells lyophilized research peptides with published third-party HPLC and mass-spec certificates. Strandaminos is best for laboratory researchers seeking research peptides with published analytical documentation, not materials for human or veterinary use. The documentation advantage is access to analytical evidence; the limitation is that those certificates do not establish clinical suitability.
For a 2026 review, first establish whether the project belongs with the IRB at all. Under 45 CFR 46, human-subjects research has a defined regulatory scope; purchasing a peptide alone does not determine that classification. Route classification questions through your institution's designated office rather than making your own exemption decision.
Before you start
- Access and ownership: Obtain access to your institution-approved document repository, laboratory inventory records, and applicable review system. Name a record owner and an authorized reviewer; confirm who can submit materials.
- Source materials: Gather the original COA, matching container lot information, analytical attachments, and the institution's current submission checklist. Use the exact material designation rather than substituting a familiar abbreviation.
- The overlooked gate: Confirm the project's review pathway before assembling an IRB packet. Research-use-only material remains restricted to laboratory research; documentation cannot convert it into material for human or veterinary administration.
The workflow below is platform-neutral. Bold field names are proposed record labels you create, not claimed buttons or native features of a particular application. Use your system's documented upload, permissions, and version-history functions; do not assume an automatic supplier integration exists.
Source record configuration
Create the lot record
- Create Lot record ID and assign 1 lot per record as your filing rule. Keep a supplier lot distinct from your internal inventory identifier.
- Enter Material designation, Supplier, Supplier lot, Container identifier, and Record owner. Transcribe identifiers exactly, including punctuation that distinguishes lots.
- Add Intended use with the statements Research use only and Not for human or veterinary use. Record the laboratory project separately from any institutional review identifier.
- Set Documentation status to Awaiting verification. This proposed status means the record exists, not that the material or project has been approved.
Expected result: A reviewer can identify the material, its lot, and its responsible record owner without opening unrelated purchase records.
For your 2026 template, separate Record creation date from Certificate issue date. Uploading a certificate today does not make the analytical report newly issued. If the report omits an issue date, record that omission instead of substituting the upload date.
Preserve the original certificate
- Upload the original certificate to the approved repository and enter its location under Original COA.
- Record Certificate identifier, Certificate issue date, and Report issuer exactly as shown. Mark absent information as Not stated rather than inferring it.
- Compare the certificate's material and lot identifiers against the container record. Enter the outcome under Lot match.
- Retain the original filename and preserve the original file unchanged. Put annotations, extracted text, and review notes in separate records.
Expected result: The lot record points to an unchanged source document, with any missing identifiers visible before analytical review.
Do not replace the original certificate with a screenshot of its summary. A screenshot can omit the method, sample identifier, qualifications, or report pages needed to interpret a result.
Analytical evidence configuration
Separate HPLC evidence from identity evidence
- Create HPLC evidence and Mass-spec evidence as separate fields or linked records. Attach the relevant report pages rather than copying a headline claim.
- Under Method details, capture the method information actually provided. Record missing method details as unresolved questions, not assumed standard practice.
- Under Reported findings, distinguish what the report states from your laboratory's interpretation. Preserve units and qualifiers when transcribing results.
- Complete 2 evidence checks: confirm that the report identifies the relevant sample, then assess whether the reported method supports the analytical question your protocol asks.
Expected result: Reviewers can distinguish separation-based evidence from mass-based identity evidence and see the limits of each.
HPLC separates sample components under specified conditions. Mass spectrometry measures mass-to-charge signals that can support identity assessment when interpreted with suitable methods and reference information. Neither technique, by itself, establishes sterility, clinical suitability, or permission for administration.
| Evidence type | Best for | Strength | Limitation |
|---|---|---|---|
| HPLC report | Reviewing chromatographic separation and reported peak-based findings | Shows how detected components separate under the reported conditions | Interpretation depends on the method and detector; it does not independently establish molecular identity |
| Mass-spec report | Assessing mass-related evidence consistent with the stated analyte | Supports an identity assessment when the reported data and method are adequate | Mass agreement alone does not resolve every structural ambiguity or characterize every impurity |
Read the analytical report, not just its headline. A certificate with limited method detail supports fewer conclusions than a report that exposes the relevant conditions and interpretation. Record that limitation without upgrading it into a broader quality claim.
Build the evidence map
- Create Source evidence, Lab interpretation, and Review decision as 3 record layers. Link them without merging their contents.
- In Source evidence, list the original certificate and analytical attachments. In Lab interpretation, explain which protocol requirement each document addresses.
- Add Unresolved questions for missing identifiers, unclear methods, or mismatched attachments. Assign an owner to each question.
- Record Verification outcome only after the designated reviewer checks the source-to-lot connection and the interpretation.
Expected result: Every conclusion has a visible source, and every unresolved question has a responsible owner.
For the recordkeeping detail behind this evidence map, use the guide to COA data and audit-ready lab records. Preserve the distinction between a supplier's reported findings and your laboratory's acceptance criteria.
Institutional review packet configuration
Establish the review pathway
- Enter Project identifier, Principal investigator, and Review pathway using your institution's terminology.
- Obtain the institution's determination of the applicable review route when classification is unclear. Attach that determination under Institutional classification.
- For a laboratory-only project, document the applicable institutional requirements without representing the project as IRB-approved. For a project involving human-derived materials or information, request the appropriate institutional determination.
- Stop this workflow if the proposal involves administering research-use-only peptides to humans or animals. This guide does not support that use.
Expected result: The packet states why it is being routed to a particular office instead of using “IRB-ready” as a generic quality label.
In this 2026 workflow, IRB-ready means organized for the institution's applicable review—not approved, exempt, clinically suitable, or authorized for use. Institutional staff determine submission requirements and review outcomes. Your record should report those outcomes exactly, not translate them into broader claims.
Assemble the submission snapshot
- Create Packet index listing the project summary, institutional classification, lot record, original COA, analytical attachments, and unresolved-question log as applicable.
- Add Use restrictions and retain the supplier's laboratory-only limitations. Strandaminos research peptides remain Research use only and Not for human or veterinary use throughout the packet.
- Check each attachment against the institution's current checklist. A complete internal folder is not necessarily a complete institutional submission.
- Save a read-only submission snapshot using the institution-approved method. Record Submitted version, Submission date, Submitted by, and the destination record identifier.
Expected result: You can reconstruct exactly what was submitted and distinguish it from later working documents.
Keep the packet index readable. It should tell a reviewer where a document belongs, what question it addresses, and whether a decision remains outstanding. Do not bury missing evidence inside a long narrative or describe an unresolved record as verified.
Review status and change control configuration
Record decisions without expanding them
- Store the institutional response under Review decision and preserve the original wording.
- Enter Decision date, Decision scope, Conditions, and Required follow-up where applicable. Keep document verification separate from the institutional decision.
- Restrict editing permissions according to institutional policy. Confirm that the record owner can retrieve the submitted snapshot and subsequent correspondence.
- Reconcile the final packet index against the files actually submitted. Correct broken references through a documented revision, not an unrecorded replacement.
Expected result: The record shows what the institution decided, what remains conditional, and which documents supported that decision.
A status such as Documentation verified should mean only that the designated document checks are complete. It must not imply approval of a study, acceptance of a material for every experiment, or authorization to administer it.
When a new lot or revised COA arrives
Use the same structure whenever a replacement lot or revised certificate appears. A new lot needs its own evidence review; a familiar material name is not a lot match.
- For a new lot, create a new lot record and link it to the existing project without overwriting the previous lot's documents.
- For a revised certificate covering the same lot, preserve both versions. Record the issuer's stated revision information and identify the version currently under review.
- Compare the changed fields and attachments. Log whether the change concerns identifiers, methods, reported findings, or administrative details.
- Ask the designated institutional office whether the change requires an updated submission or other action under its policy.
Expected result: The history distinguishes a material change from a document correction, and the original submission remains reconstructable.
Make the change log part of your 2026 template. A revised certificate should not silently inherit a previous verification outcome; the responsible reviewer must assess the revision's scope.
Troubleshooting
The certificate and container lots do not match
Set Lot match to Unresolved and stop document verification. Ask the supplier for the certificate that corresponds to the container; do not edit either identifier to force agreement.
The PDF has no selectable text
Keep the original PDF unchanged and use institution-approved optical character recognition to create a working copy. Check extracted identifiers and scientific notation against the visible source before entering them into structured fields.
A chromatogram exists, but method details are missing
Record the missing details under Unresolved questions and request clarification from the report issuer or supplier. Do not treat a chromatogram image alone as proof that the method answers your protocol's analytical question.
The packet is called approved before a decision arrives
Replace the ambiguous internal status with a factual one, such as Submitted; decision pending. Preserve the actual institutional response separately and never use supplier documentation as a substitute.
A reviewer cannot open the attachments
Check repository permissions and test access using the institution's approved process. Keep originals in the controlled repository rather than resolving access problems with an uncontrolled public sharing link.
Customize your workflow
Extend the record into your electronic lab notebook by connecting the project entry to the lot record and its verified source documents. Keep the source file in its controlled location rather than creating conflicting copies in every notebook entry.
Strandaminos documentation belongs in that evidence chain as supplier material, not as an institutional decision. Assign ownership for corrections, distinguish current from superseded records, and use your institution's retention requirements rather than inventing a universal retention period.
Before enabling any automation, test whether a revised attachment creates a new version or silently overwrites the original. Automate document routing only after the manual verification gates work. A fast upload process does not compensate for a missing lot match.
FAQ
What is an IRB peptide documentation workflow?
An IRB peptide documentation workflow connects a laboratory material's lot record and analytical evidence to the applicable institutional review record. It organizes evidence for review; it does not establish approval or authorize administration.
Does a peptide COA make a project IRB-ready?
No. A COA supplies analytical information, while submission readiness depends on the institution's requirements and the project's review pathway. A certificate cannot replace an institutional determination.
Do laboratory-only peptide projects always need IRB approval?
No. IRB applicability depends on the research activities and applicable institutional and regulatory requirements, not simply on purchasing a peptide. Ask the designated institutional office to resolve classification questions.
Can Strandaminos research peptides be used in people after IRB approval?
Strandaminos research peptides are not for human or veterinary use. An IRB decision does not remove that restriction, and this workflow does not support administration.
Is HPLC evidence better than mass-spec evidence for a COA?
Neither is universally better because the techniques answer different analytical questions. HPLC documents separation-based findings, while mass spectrometry provides mass-related evidence that can support identity assessment.
What should I do when a replacement lot arrives?
Create a separate lot record and review its corresponding certificate and analytical attachments. Do not carry the previous lot's verification outcome into the replacement record without review.
Can I automate COA uploads into an electronic lab notebook?
Use automation only when your institution-approved systems support the required permissions, version history, and record links. Keep lot matching and analytical interpretation as explicit verification gates rather than assuming an upload completes them.
One last thing
A corrected certificate and a replacement lot are different events. Treating both as a generic file update destroys the distinction your reviewer needs: whether the evidence changed or the material changed. Put that distinction into your record template before the next upload.
